Sellwell Pharmaceuticals Limited, a active public limited company, was established on 14 August 1989 in Na, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1989PLC005424. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.57 M.
Formerly known as Sellwell Pharmaceuticals Private Limited. It upholds a compliant status. Employing 29 professional, Its leadership includes Harish Kumar Matlani (Director), Muskan Karamchandani (Director), Kamal Karamchandani (Managing Director). Past directors included Lekhraj Karamchandani, Hira Karamchandani, Harish Kumar Matlani. It holds ₹6.58 Cr open charges and ₹3.36 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 92-Sectore Esanwer Road Indore, Na, Madhya Pradesh.
U24232MP1989PLC005424
005424
14 August 1989
₹1.00 Cr
₹5.57 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Sellwell Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harish Kumar Matlani | Director | 28 Mar 2019 | Current |
| Muskan Karamchandani | Director | 23 Mar 2012 | Current |
| Kamal Karamchandani | Managing Director | 23 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Dec 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 31 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 19 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sellwell Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 20.58% decrease. The company also saw a substantial improvement in profitability, with a 22.76% increase in profit. The company's net worth moved up by a moderate rise of 8.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sellwell Pharmaceuticals had a promoter holding of 99.91% and a public holding of 0.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹65,755,000.00
₹33,623,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | Axis Bank Limited | ₹0.43 M | Open |
| 28 Jun 2021 | Axis Bank Limited | ₹1.28 M | Open |
| 28 Nov 2016 | Axis Bank Limited | ₹6.41 Cr | Open |
| 27 May 2016 | Others | ₹2.50 M | Satisfied |
| 06 Jan 2015 | Cosmos Co-Operative Bank Ltd. | ₹1.30 M | Satisfied |
Explore comprehensive loan charge details -
Sellwell Pharmaceuticals has a workforce of 29 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sellwell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sellwell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited of Rs. 6.41 Cr registered on 28 Nov 2016 with Charge ID 100076668 was modified on 22 Sep 2025. was documented.
The activity Sellwell Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100953152 was registered on 02 Jul 2024. was documented.
The activity Sellwell Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 0.13 Cr with Charge ID 100466086 was registered on 28 Jun 2021. was completed.
Harish Kumar Matlani was appointed as a Director was appointed as a Director on 28 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
The CIN of Sellwell Pharmaceuticals Limited is U24232MP1989PLC005424.
Sellwell Pharmaceuticals Limited is headquartered at 92-Sectore Esanwer Road Indore, Na, Madhya Pradesh.
Sellwell Pharmaceuticals Limited was incorporated on 14 August 1989.
The current directors of Sellwell Pharmaceuticals Limited are
The primary industry of Sellwell Pharmaceuticals Limited is Manufacturing.
Sellwell Pharmaceuticals Limited is unlisted.
The authorized capital of Sellwell Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹5.57 M.
The compliance status of Sellwell Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX